✦ LIBER ✦

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

✍ Scribed by Giorgio V. Scagliotti; Keunchil Park; Shekar Patil; Janusz Rolski; Tuncay Goksel; Renato Martins; Steven J.M. Gans; Carla Visseren-Grul; Patrick Peterson

Book ID: 116430056
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 236 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2009.04.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1BA Phase III study of pemetrexed plus c

1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

✍ C. Manegold; R. Digumarti; M. Zukin; F. de Marinis; A. Mellemgaard; D. Gandara; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Randomized, multicenter, phase II study

Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

P382 A randomized phase II trial of sequ

P382 A randomized phase II trial of sequential gemcitabine plusvinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaïve patients with stage III and IV non-small cell lung cancer (NSCLC)

✍ Teodorescu, G.; Ciuleanu, T.; Grigorescu, A.; Firoiu, E.; Ruta Muresan, D. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Sunitinib in combination with gemcitabin

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

✍ Reck, Martin; Frickhofen, Norbert; Cedres, Susana; Gatzemeier, Ulrich; Heigener, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Docetaxel plus cisplatin versus docetaxe

Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

A phase II study of paclitaxel plus cisp

A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients

✍ Hiroshi Sakai; Shuichi Yoneda; Tomohide Tamura; Yutaka Nishiwaki; Akira Yokoyama 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 77 KB